Examination of links between herpes zoster incidence and childhood varicella vaccination

Annals of Internal Medicine

Volumn 159, Issue 11, 2013, Pages 739-745

  Hales, Craig M ^a   Harpaz, Rafael ^a   Joesoef, M Riduan ^a   Bialek, Stephanie R ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ACCURACY; AGE DISTRIBUTION; AGED; ARTICLE; CHICKENPOX; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; HEALTH CARE ACCESS; HELP SEEKING BEHAVIOR; HERPES ZOSTER; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNITED STATES; VACCINATION;

EID: 84890306931     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-11-201312030-00006     Document Type: Article

References (51)

1. Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington, DC: Public Health Foundation; 2012.
2. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003;70 Suppl 1:S111-8. [PMID: 12627498]
3. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341-9. [PMID: 17976353]
4. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635-45. [PMID: 10699164]
5. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731-6. [PMID: 20921251]
6. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40. [PMID: 17585291]
7. Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197 Suppl 2:S185-90. [PMID: 18419395]
8. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. [PMID: 14267505]
9. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500-7. [PMID: 12057605]
10. Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996;173:450-3. [PMID: 8568309]
11. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002; 360:678-82. [PMID: 12241874]
12. Donahue JG, Kieke BA, Gargiullo PM, Jumaan AO, Berger NR, McCauley JS, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health. 2010;100:1116-22. [PMID: 20075320]
13. Chaves SS, Santibanez TA, Gargiullo P, Guris D. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep. 2007;122:155-9. [PMID: 17357357]
14. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect. 1992;108:513-28. [PMID: 1318219]
15. U.K. Health Protection Agency. Latest HPA modelling reveals chickenpox vaccination would lead to more shingles among elderly despite introduction of shingles vaccination [press release]. 17 September 2008. Accessed at www.hpa.org.uk/NewsCentre/NationalPressReleases/2008PressReleases/ 080917chickenpox/ on 1 July 2013.
16. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-6. [PMID: 6981045]
17. Jumaan AO, Seward JF, Wooten K, Singelton J. Varicella and herpes zoster surveillance in the US, 1970-1994 [Abstract]. In: Programs and Abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, 9-12 October 2003. Alexandria, VA: Infectious Diseases Soc America; 2003: 899. Abstract 899.
18. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133:245-53. [PMID: 15816149]
19. Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52:332-40. [PMID: 21217180]
20. Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135:908-13. [PMID: 17291380]
21. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30. [PMID: 18528318]
22. Centers for Disease Control and Prevention (CDC). Adult vaccination coverage-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:66-72. [PMID: 22298302]
23. ResDac. Accessed at www.resdac.org on 1 July 2013.
24. Agency for Healthcare Research and Quality. Creation of New Race-Ethnicity Codes and Socioeconomic Status (SES) Indicators for Medicare Beneficiaries. 2008. Accessed at www.ahrq.gov/qual/medicareindicators/ medicareindicators2.htm on 24 January 2012.
25. Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Washington, DC: Government Printing Office; 1996.
26. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001:1-10. [PMID: 11676466]
27. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347:340-6. [PMID: 12151472]
28. Kleinbaum D, Kupper L, Muller K, Nizam A. Applied Regression Analysis and Multivariable Methods. Washington, DC: Duxbury Pr; 1998.
29. Centers for Disease Control and Prevention. U.S. Vaccination Coverage Reported via National Immunization Survey. 2013. Accessed at www.cdc.gov/vaccines/stats-surv/nis/ on 1 July 2013.
30. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008;197 Suppl 2:S71-5. [PMID: 18419413]
31. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, Sharp P, Anderson WJ, et al; Division of Notifiable Diseases and Healthcare Information, Office of Surveillance, Epidemiology, and Laboratory Services, CDC. Summary of notifiable diseases - United States, 2011. MMWR Morb Mortal Wkly Rep. 2013;60:1-117. [PMID: 23820934]
32. Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29:8580-4. [PMID: 21939721]
33. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005;191:2002-7. [PMID: 15897984]
34. Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect. 2012;140:1131-40. [PMID: 21906410]
35. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol. 2004;72:174-9. [PMID: 14635028]
36. Ljungman P, Lönnqvist B, Gahrton G, Ringdén O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis. 1986;153:840-7. [PMID: 3009635]
37. Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis. 1977;135:659-63. [PMID: 192807]
38. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5:e74. [PMID: 18366252]
39. Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495-522. [PMID: 10844714]
40. Fleming DM, Bartelds A, Chapman RS, Cross KW. The consistency of shingles and its significance for health monitoring. Eur J Epidemiol. 2004;19: 1113-8. [PMID: 15678791]
41. Pérez-Farinós N, Ordobás M, García- Fernández C, García-Comas L, Cañellas S, Rodero I, et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis. 2007;7:59. [PMID: 17570859]
42. Joesoef RM, Harpaz R, Leung J, Bialek SR. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012;87:961-7. [PMID: 23036671]
43. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26-33. [PMID: 14720565]
44. Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16:692-5. [PMID: 16516488]
45. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305:160-6. [PMID: 21224457]
46. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748-53. [PMID: 16050886]
47. Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect. 2004;132:1-5. [PMID: 14979582]
48. Schmader K, George LK, Burchett BM, Pieper CF. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis. 1998;178 Suppl 1:S67-70. [PMID: 9852978]
49. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2002. Final rule with comment period. Fed Regist. 2001;66:55245-503. [PMID: 11760761]
50. Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27:882-7. [PMID: 19071175]
51. Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011;174:1054-61. [PMID: 21920944]